SAN DIEGO, Nov. 04, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical firm devoted to the event of programmed mobile immunotherapies for sufferers with most cancers, right now introduced that the Company will current at the next upcoming investor conferences:
- Cowen’s sixth Annual IO Next Summit obtainable on demand on Friday, November 11, 2022 at 2:10 PM ET
- Jefferies London Healthcare Conference on Wednesday, November 16, 2022 at 12:55 PM GMT, 7:55 AM ET, in London, United Kingdom
- Piper Sandler 34th Annual Healthcare Conference on Tuesday, November 29, 2022 at 12:00 PM ET in New York, New York
A dwell webcast, if recorded, of every presentation may be accessed beneath “Events & Presentations” within the Investors part of the Company’s web site at www.fatetherapeutics.com. The archived webcast will likely be obtainable on the Company’s web site shortly after the occasion.
About Fate Therapeutics, Inc.
Fate Therapeutics is a clinical-stage biopharmaceutical firm devoted to the event of first-in-class mobile immunotherapies for sufferers with most cancers. The Company has established a management place within the medical improvement and manufacture of common, off-the-shelf cell merchandise utilizing its proprietary induced pluripotent stem cell (iPSC) product platform. The Company’s immuno-oncology pipeline contains off-the-shelf, iPSC-derived pure killer (NK) cell and T-cell product candidates, that are designed to synergize with well-established most cancers therapies, together with immune checkpoint inhibitors and monoclonal antibodies, and to goal tumor-associated antigens utilizing chimeric antigen receptors (CARs). Fate Therapeutics is headquartered in San Diego, CA. For extra data, please go to www.fatetherapeutics.com.
Contact:
Christina Tartaglia
Stern Investor Relations, Inc.
212.362.1200
[email protected]
